Literature DB >> 29407071

Amputation versus conservative treatment in severe open lower-limb fracture: A functional and quality-of-life study.

M Fioravanti1, P Maman1, G Curvale1, A Rochwerger1, J-C Mattei2.   

Abstract

INTRODUCTION: Severe lower-limb trauma is a major event in a patient's life, and treatment is a challenge that has not been sufficiently studied. The main objective of the present study was to assess the difference in disability between amputees and patients who kept their leg after severe open lower-limb fracture. HYPOTHESIS: The study hypothesis was that amputation allows better functional recovery and quality of life, in the same time-frame.
MATERIALS AND METHODS: All male and female patients aged over 18 years admitted to one of the trauma centers of Marseille (France) for major lower-limb trauma with Gustilo IIIb or IIIc fracture were included. Minimum follow-up was 2 years. Two groups were distinguished according to primary treatment: lower-limb salvage, or amputation. Rates of infection and of surgical revision, hospital stay, functional parameters (walking distance, standing, use of canes, running, jumping, driving, and physical and occupational activity) and quality of life (MOS SF-36 score) were compared between groups.
RESULTS: The conservative treatment group comprised 27 patients, and the amputation group 24. Rates of infection and of surgical revision and hospital stay were significantly lower in the amputation group (P<0.02). All functional parameters (except return to work) and overall quality of life were significantly better in the amputation group. There was no significant inter-group difference in MOS mental score.
CONCLUSION: In severe lower-limb trauma, amputation seems to give better functional and quality-of-life results. It did not, however, improve return to work, and was not better accepted psychologically than long and complex conservative management. LEVEL OF EVIDENCE: IV, retrospective study.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Amputation; Complications; Conservative treatment; Disability; Functional outcome; Lower limb; MOS SF-36; Open fracture; Quality of life; Severity

Mesh:

Year:  2018        PMID: 29407071     DOI: 10.1016/j.otsr.2017.12.013

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  5 in total

1.  Analysis of bone transport for ankle arthrodesis as a limb salvage procedure for the treatment of septic pilon fracture nonunion.

Authors:  Thomas Rosteius; Sebastian Lotzien; Matthias Königshausen; Valentin Rausch; Charlotte Cibura; Björn Behr; Markus Lehnhardt; Thomas Armin Schildhauer; Jan Geßmann
Journal:  Sci Rep       Date:  2021-12-28       Impact factor: 4.379

2.  Study on the relationship between the timing of conversion from external fixation to internal fixation and infection in the treatment of open fractures of extremities.

Authors:  Zelin Ye; Shanwen Zhao; Canjun Zeng; Ziheng Luo; Song Yuan; Runguang Li
Journal:  J Orthop Surg Res       Date:  2021-11-07       Impact factor: 2.359

3.  Effects of 1-stage revascularization and temporary external fixation combined with 2-stage Ilizarov technique in the treatment of bone defects in lower limb destruction injury: A case report.

Authors:  Ying-Jie Xu; Xu Gao; Hao Ding; Xian-Min Bu; Hai-Bin Wang; Bin Wu
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

4.  Comparison of patient-reported outcomes at one year after injury between limb salvage and amputation: A prospective cohort study.

Authors:  Taketo Kurozumi; Takahiro Inui; Yuhei Nakayama; Akifumi Honda; Kentaro Matsui; Keisuke Ishii; Takashi Suzuki; Yoshinobu Watanabe
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

5.  The socioeconomic impact of orthopaedic trauma: A systematic review and meta-analysis.

Authors:  Nathan N O'Hara; Marckenley Isaac; Gerard P Slobogean; Niek S Klazinga
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.